Records containing: Ocular Hypertension
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2014-07-24Compliance Study Comparing DuoTrav to TRAVATAN Plus Timolol Using the Dosing Aid
-
CLINICAL_TRIALS study record update · 2014-07-22ClinicalTrials.gov study NCT02003534
-
CLINICAL_TRIALS study record update · 2014-07-21ClinicalTrials.gov study NCT02020512
-
CLINICAL_TRIALS study record update · 2014-07-21An Open-Label, Pharmacokinetic and Safety Study of Travoprost Ophthalmic Solution, 0.004% in Pediatric Glaucoma or Ocular Hypertension Patients
-
CLINICAL_TRIALS study record update · 2014-07-18A Twelve-Month Open-Label Safety Study of Polyquaternium-Preserved DuoTrav APS Dosed Once Daily in Patients With Open-Angle Glaucoma or Ocular Hypertension
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2014-07-16A Six-Week, Multi-Center, Double-Masked, Safety and Efficacy Study of Travoprost 0.004%/Timolol 0.5% BAC-free Compared to Travoprost 0.004%/Timolol 0.5% in Patients With Open-Angle Glaucoma or Ocular Hypertension
-
CLINICAL_TRIALS study record update · 2014-07-16A Six-Week, Multi-Center, Double-Masked, Safety and Efficacy Study of Travoprost 0.004%/Timolol 0.5% BAC-free Compared to Travoprost 0.004%/Timolol 0.5% in Patients With Open-Angle Glaucoma or Ocular Hypertension
-
CLINICAL_TRIALS study record update · 2014-07-15ClinicalTrials.gov study NCT00761709
-
CLINICAL_TRIALS study record update · 2014-07-15ClinicalTrials.gov study NCT00892762
-
CLINICAL_TRIALS study record update · 2014-07-11A Single Dose Patient Preference Study Comparison in Patients With Open-Angle Glaucoma or Ocular Hypertension
-
CLINICAL_TRIALS study record update · 2014-07-10Comparison of Safety and IOP-Lowering Efficacy of Three Alternative Travoprost Formulations to Vehicle and TRAVATAN® in Patients With Open-Angle Glaucoma or Ocular Hypertension
-
CLINICAL_TRIALS study record update · 2014-07-01Assessing the Efficacy and Tolerability of AZARGA® (Brinzolamide 1%/Timolol 0.5% Fixed Combination) as Replacement Therapy in Patients on COMBIGAN® (Brimonidine 0.2%/Timolol 0.5% Fixed Combination) Therapy in Canada
-
CLINICAL_TRIALS study record update · 2014-06-1924-hour IOP-lowering Effect of 0.01% Bimatoprost
-
CLINICAL_TRIALS study record update · 2014-06-18ClinicalTrials.gov study NCT02061683
-
CLINICAL_TRIALS study record update · 2014-06-13ClinicalTrials.gov study NCT01646151
-
CLINICAL_TRIALS study record update · 2014-06-13Multi-Center Study Comparing Efficacy and Tolerability of TRAVATAN® BAK-free (0.004% Travoprost) in Patients Previously on Latanoprost Ophthalmic Solution 0.005% Monotherapy
-
CLINICAL_TRIALS study record update · 2014-06-13ClinicalTrials.gov study NCT01589510
-
CLINICAL_TRIALS study record update · 2014-05-26Ocular Hypertension And Yoga Study
-
CLINICAL_TRIALS study record update · 2014-05-21Utility of Heidelberg Retina Tomograph in Monitoring Glaucoma Progression
-
CLINICAL_TRIALS study record update · 2014-05-19Efficacy and Safety of Adding the Brinzolamide/Timolol Maleate Fixed Combination (AZARGA®) to Ocular Hypertensive or Glaucoma Patients Uncontrolled on Prostaglandin Monotherapy
-
CLINICAL_TRIALS study record update · 2014-05-1224-Hour Intraocular Pressure (IOP) And Blood Pressure Control In Glaucoma And Ocular Hypertension Patients
-
CLINICAL_TRIALS study record update · 2014-05-09Multi-Center Study Assessing the Efficacy and Tolerability of TRAVATAN® Solution Without BAK, Containing Polyquad® Preservative (0.004% Travoprost) in Patients Previously on Latanoprost 0.005% or Bimatoprost 0.01% Ophthalmic Solution Monotherapy
-
CLINICAL_TRIALS study record update · 2014-05-09A Phase III, Randomized, Active Comparator-Controlled, Four-Week, Double-Masked Clinical Trial to Compare the Efficacy and Safety of Preservative-Free MK-2452 (0.0015%) and Preservative-Free Timolol Maleate (0.5%) in Patients With Open-Angle Glaucoma or Ocular Hypertension in India
-
CLINICAL_TRIALS study record update · 2014-05-08A Phase 2, Double-masked, Randomized, Active-controlled, Crossover Study Assessing the Safety and Ocular Hypotensive Efficacy of AR-12286 or Timolol Added to Patients With Elevated Intraocular Pressure Currently Using Latanoprost
-
CLINICAL_TRIALS study record update · 2014-05-02A Single Centre, Placebo-Controlled, Double-Masked, Sequential Designed Study to Evaluate 3 Ophthalmic Formulations of AMA0076 in Healthy Subjects